089 - Use of Vasopressin and Norepinephrine in Neonatal septic shock- A multi-center retrospective cohort study

Renjini Lalitha, The University of Western Ontario - Schulich School of Medicine & Dentistry, London, ON, Canada; Najlaa Abdulaziz, No, Madinah, Al Madinah, Saudi Arabia; Michael Miller, The University of Western Ontario - Schulich School of Medicine & Dentistry, London, ON, Canada; Kelly L. Mendham, London Health Sciences Centre, London, ON, Canada; Ashraf Kharrat, Mount Sinai Hospital, Toronto, ON, Canada; Gabriella Ripstein, University of Ottawa Faculty of Medicine, Toronto, ON, Canada; Sebastien Joye, centre universitaire hospitalier vaudois, Lausanne, Vaud, Switzerland; Poorva Deshpande, Mount Sinai Hospital, Toronto, ON, Canada; Michelle Baczynski, Mount Sinai Hospital, Toronto, ON, Canada; Faith Zhu, Faith Zhu, Staff Neonatologist, Mount Sinai Hospital, Toronto, Toronto, ON, Canada; Amish Jain, University of Toronto Temerty Faculty of Medicine, Toronto, ON, Canada; Sagee Nissimov, Shamir Medical Center, Ramat Hasharon, HaMerkaz, Israel; Audrey Hebert, CHU de Quebec - Universite Laval, Quebec city, PQ, Canada; Simon Ouellet, Faculty of Medicine Université Laval, Quebec, PQ, Canada; Marie-Eve Leclerc, Faculty of Medicine Université Laval, Québec, PQ, Canada; Soume Bhattacharya, Western University, London, ON, Canada